Shamir R. Mehta

30.5k total citations · 9 hit papers
226 papers, 16.1k citations indexed

About

Shamir R. Mehta is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Shamir R. Mehta has authored 226 papers receiving a total of 16.1k indexed citations (citations by other indexed papers that have themselves been cited), including 199 papers in Cardiology and Cardiovascular Medicine, 107 papers in Surgery and 46 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Shamir R. Mehta's work include Acute Myocardial Infarction Research (137 papers), Antiplatelet Therapy and Cardiovascular Diseases (102 papers) and Coronary Interventions and Diagnostics (83 papers). Shamir R. Mehta is often cited by papers focused on Acute Myocardial Infarction Research (137 papers), Antiplatelet Therapy and Cardiovascular Diseases (102 papers) and Coronary Interventions and Diagnostics (83 papers). Shamir R. Mehta collaborates with scholars based in Canada, United States and United Kingdom. Shamir R. Mehta's co-authors include Salim Yusuf, Ron J.G. Peters, Keith A.A. Fox, Susan Chrolavicius, Sanjit S. Jolly, John W. Eikelboom, Basil S. Lewis, Sonia S. Anand, Madhu K. Natarajan and Andrzej Budaj and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Shamir R. Mehta

218 papers receiving 15.3k citations

Hit Papers

Effects of pretreatment with clopidogrel and aspirin foll... 2001 2026 2009 2017 2002 2001 2011 2006 2008 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study
    2002 2.0k citations Shamir R. Mehta, Salim Yusuf et al. profile →
  2. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study
    2001 2.0k citations Shamir R. Mehta, Salim Yusuf et al. profile →
  3. Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial
    2011 1.4k citations Sanjit S. Jolly, Salim Yusuf et al. profile →
  4. Adverse Impact of Bleeding on Prognosis in Patients With Acute Coronary Syndromes
    2006 981 citations John W. Eikelboom, Shamir R. Mehta et al. Circulation profile →
  5. Radial versus femoral access for coronary angiography or intervention and the impact on major bleeding and ischemic events: A systematic review and meta-analysis of randomized trials
    2008 747 citations Sanjit S. Jolly, Salim Yusuf et al. profile →
  6. Benefits and Risks of the Combination of Clopidogrel and Aspirin in Patients Undergoing Surgical Revascularization for Non–ST-Elevation Acute Coronary Syndrome
    2004 598 citations Keith A.A. Fox, Shamir R. Mehta et al. Circulation profile →
  7. Early versus Delayed Invasive Intervention in Acute Coronary Syndromes
    2009 582 citations Shamir R. Mehta, Christopher B. Granger et al. profile →
  8. Routine vs Selective Invasive Strategies in Patients With Acute Coronary Syndromes
    2005 515 citations Shamir R. Mehta, Keith A.A. Fox et al. profile →
  9. Ticagrelor in Patients with Stable Coronary Disease and Diabetes
    2019 204 citations Philippe Gabríel Steg, Deepak L. Bhatt et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shamir R. Mehta Canada 49 13.2k 7.5k 4.0k 3.2k 2.4k 226 16.1k
John A. Bittl United States 50 11.4k 0.9× 8.9k 1.2× 2.5k 0.6× 2.3k 0.7× 4.4k 1.8× 137 15.1k
Peter B. Berger United States 76 16.2k 1.2× 10.5k 1.4× 3.5k 0.9× 2.5k 0.8× 3.6k 1.5× 360 22.6k
C. Michael Gibson United States 53 11.8k 0.9× 6.8k 0.9× 2.2k 0.5× 1.2k 0.4× 3.9k 1.6× 220 15.1k
Derek P. Chew Australia 56 13.1k 1.0× 6.2k 0.8× 2.0k 0.5× 1.2k 0.4× 3.9k 1.6× 343 16.2k
Ralph G. Brindis United States 65 15.5k 1.2× 7.1k 1.0× 1.6k 0.4× 2.9k 0.9× 5.2k 2.1× 157 20.7k
Vittorio Pengo Italy 63 6.6k 0.5× 2.4k 0.3× 5.8k 1.5× 1.7k 0.5× 1.7k 0.7× 367 16.3k
Basil S. Lewis Israel 52 20.1k 1.5× 8.6k 1.2× 6.9k 1.7× 2.7k 0.9× 2.5k 1.0× 278 28.0k
Gilles Montalescot France 80 23.1k 1.7× 12.3k 1.7× 5.8k 1.5× 2.7k 0.9× 3.3k 1.4× 553 28.8k
Petr Widimský Czechia 45 7.1k 0.5× 4.2k 0.6× 1.3k 0.3× 1.9k 0.6× 2.0k 0.8× 276 9.3k
Venu Menon United States 52 8.4k 0.6× 5.6k 0.8× 975 0.2× 1.4k 0.4× 1.1k 0.5× 298 14.2k

Countries citing papers authored by Shamir R. Mehta

Since Specialization
Citations

This map shows the geographic impact of Shamir R. Mehta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shamir R. Mehta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shamir R. Mehta more than expected).

Fields of papers citing papers by Shamir R. Mehta

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shamir R. Mehta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shamir R. Mehta. The network helps show where Shamir R. Mehta may publish in the future.

Co-authorship network of co-authors of Shamir R. Mehta

This figure shows the co-authorship network connecting the top 25 collaborators of Shamir R. Mehta. A scholar is included among the top collaborators of Shamir R. Mehta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shamir R. Mehta. Shamir R. Mehta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kotanidis, Christos P., Shamir R. Mehta, Erik Badings, et al.. (2025). Early Versus Delayed Invasive Management of Female Patients With Non–ST-Elevation Acute Coronary Syndrome: An Individual Patient Data Meta-Analysis. Circulation Cardiovascular Interventions. 18(3). e014763–e014763. 2 indexed citations
2.
Naik, Hursh, Matthew J. Price, Samir Kapadia, et al.. (2025). Tricuspid Transcatheter Edge-to-Edge Repair in Patients With Transvalvular CIED Leads. JACC. Clinical electrophysiology. 11(5). 1012–1020. 1 indexed citations
3.
Kunadian, Vijay, David Wood, Robert F. Storey, et al.. (2023). Complete Revascularization Versus Culprit-Lesion-Only PCI in STEMI Patients With Diabetes and Multivessel Coronary Artery Disease: Results From the COMPLETE Trial. Circulation Cardiovascular Interventions. 16(9). e012867–e012867. 6 indexed citations
4.
Leong, Darryl P., Nazanin Aghel, Peter Ellis, et al.. (2023). Cardiac Interventions in Patients With Active, Advanced Solid and Hematologic Malignancies. JACC CardioOncology. 5(4). 415–430. 14 indexed citations
5.
6.
Bossard, Matthias, Peggy Gao, William E. Boden, et al.. (2021). Antiplatelet therapy in patients with myocardial infarction without obstructive coronary artery disease. Heart. 107(21). 1739–1747. 29 indexed citations
7.
Pinilla‐Echeverri, Natalia, Shamir R. Mehta, Wang Jia, et al.. (2020). Nonculprit Lesion Plaque Morphology in Patients With ST-Segment–Elevation Myocardial Infarction. Circulation Cardiovascular Interventions. 13(7). e008768–e008768. 71 indexed citations
8.
Caterina, Raffaele De, Dimitar Raev, Shamir R. Mehta, et al.. (2020). Comparison of Dabigatran Plus a P2Y12 Inhibitor With Warfarin-Based Triple Therapy Across Body Mass Index in RE-DUAL PCI. The American Journal of Medicine. 133(11). 1302–1312. 3 indexed citations
9.
Baber, Usman, Rishi Chandiramani, Shamir R. Mehta, et al.. (2020). Safety and efficacy of the bioabsorbable polymer everolimus‐eluting stent versus durable polymer drug‐eluting stents in high‐risk patients undergoing PCI: TWILIGHT‐SYNERGY. Catheterization and Cardiovascular Interventions. 97(1). 63–71. 4 indexed citations
10.
Gupta, Saurabh, Emilie P. Belley‐Côté, Arjun Pandey, et al.. (2020). Antiplatelet therapy and coronary artery bypass grafting: a systematic review and network meta-analysis. Interactive Cardiovascular and Thoracic Surgery. 31(3). 354–363. 10 indexed citations
11.
Gupta, Saurabh, et al.. (2019). Antiplatelet Therapy and Coronary Artery Bypass Grafting: Analysis of Current Evidence With a Focus on Acute Coronary Syndrome. Canadian Journal of Cardiology. 35(8). 1030–1038. 8 indexed citations
12.
Gupta, Saurabh, Emilie P. Belley‐Côté, Bram Rochwerg, et al.. (2019). Antiplatelet therapy and coronary artery bypass grafting. Medicine. 98(34). e16880–e16880. 3 indexed citations
13.
Lamelas, Pablo, Jon-David Schwalm, Darryl P. Leong, et al.. (2018). Varying Effects of Body Mass Index and Mortality in Different Risk Groups. The American Journal of Cardiology. 122(7). 1155–1160. 8 indexed citations
14.
Nadra, Imad, Simon D. Robinson, Eric Fretz, et al.. (2018). The prognostic impact of revascularization strategy in acute myocardial infarction and cardiogenic shock: Insights from the British Columbia Cardiac Registry. Catheterization and Cardiovascular Interventions. 92(5). E356–E367. 14 indexed citations
15.
Kereiakes, Dean J., Ian T. Meredith, Stephan Windecker, et al.. (2014). Primary Outcomes of the EVOLVE II Trial: A Prospective Randomized Investigation of a Novel Bioabsorbable Polymer-Coated, Everolimus-Eluting Coronary Stent. Circulation. 130(23). 2111–2111. 3 indexed citations
16.
Lamy, André, et al.. (2014). Cost Implication of an Early Invasive Strategy on Weekdays and Weekends in Patients With Acute Coronary Syndromes. Canadian Journal of Cardiology. 31(3). 314–319. 5 indexed citations
17.
Eikelboom, John W., Shamir R. Mehta, Keith A.A. Fox, Janice Pogue, & Salim Yusuf. (2008). Abstract 4585: Efficacy and Safety of Clopidogrel in Acute Coronary Syndrome Patients at High Risk of Bleeding: Data from the CURE Trial. Circulation. 118. 2 indexed citations
18.
Tran, Huyen, Shamir R. Mehta, & John W. Eikelboom. (2006). Clinical update on the therapeutic use of clopidogrel: treatment of acute ST-segment elevation myocardial infarction (STEMI). SHILAP Revista de lepidopterología. 1 indexed citations
19.
Eikelboom, John W., Mark Feldman, Shamir R. Mehta, et al.. (2005). Aspirin resistance and its implications in clinical practice.. PubMed. 7(3). 76–76. 6 indexed citations
20.
Weintraub, William S., Elizabeth M. Mahoney, Shamir R. Mehta, et al.. (2004). 1137-77 Long-term cost-effectiveness of clopidogrel in patients having percutaneous coronary intervention early after acute coronary syndrome: Results from PCI-CURE. Journal of the American College of Cardiology. 43(5). A296–A296. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John A. Bittl Breakdown of academic impact, for papers by Peter B. Berger Breakdown of academic impact, for papers by C. Michael Gibson Breakdown of academic impact, for papers by Derek P. Chew Breakdown of academic impact, for papers by Ralph G. Brindis Breakdown of academic impact, for papers by Vittorio Pengo Breakdown of academic impact, for papers by Basil S. Lewis Breakdown of academic impact, for papers by Gilles Montalescot Breakdown of academic impact, for papers by Petr Widimský Breakdown of academic impact, for papers by Venu Menon
Rankless by CCL
2026